Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration.
Glassmann, Alexander
Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration. [electronic resource] - International journal of oncology Dec 2011 - 1567-75 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-2423
10.3892/ijo.2011.1165 doi
Animals
Butadienes--pharmacology
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Enzyme Inhibitors--pharmacology
Glioma--enzymology
Humans
MAP Kinase Signaling System--drug effects
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Neoplastic Stem Cells--metabolism
Nitriles--pharmacology
Rats
Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration. [electronic resource] - International journal of oncology Dec 2011 - 1567-75 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-2423
10.3892/ijo.2011.1165 doi
Animals
Butadienes--pharmacology
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Enzyme Inhibitors--pharmacology
Glioma--enzymology
Humans
MAP Kinase Signaling System--drug effects
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Neoplastic Stem Cells--metabolism
Nitriles--pharmacology
Rats